Onconova Therapeutics (NASDAQ:ONTX) reported its Q1 earnings results on Monday, May 15, 2023 at 04:18 PM.
Here's what investors need to know about the announcement.
Earnings
Onconova Therapeutics beat estimated earnings by 6.67%, reporting an EPS of $-0.28 versus an estimate of $-0.3.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 1.91% increase in the share price the next day.
Here's a look at Onconova Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.21 | -0.21 | -0.19 |
| EPS Actual | -0.26 | -0.26 | -0.19 | -0.20 |
| Revenue Estimate | 60K | 60K | 60K | 80K |
| Revenue Actual | 56K | 57K | 57K | 56K |
To track all earnings releases for Onconova Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
